Machado-Joseph disease: an autosomal dominant motor system degeneration
- PMID: 1620135
- DOI: 10.1002/mds.870070302
Machado-Joseph disease: an autosomal dominant motor system degeneration
Abstract
Machado-Joseph disease is an autosomal dominant spinocerebellar degeneration. It expresses itself clinically with variable expression. Type one patients have early onset with a rapid progression of symptoms including spasticity, rigidity and myokymia. Type two patients are the most common phenotype with ataxia and spasticity. Type three patients develop progressive ataxia with variable amyotrophy. All patients have ophthalmoparesis and normal mental status. The neuropathology consists of neuronal loss and gliosis in the substantia nigra, motor cranial nuclei, dentate nucleus of the cerebellum, and variable neuronal loss with gliosis in the cerebellar cortex and neostriatum. The cerebral cortex is normal histologically. The inferior olivary nuclei are normal, thus separating this disease from olivopontocerebellar atrophy (OPCA). The disease has a worldwide distribution including families described in Portugal, the Azores, Spain, Italy, United States, Canada, Brazil, China, Taiwan, and Japan. The gene has not been mapped for this disease but the locus on chromosome 6p mapped for most families with OPCA has been excluded for this disorder.
Similar articles
-
Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies.Mov Disord. 1992;7(3):204-8. doi: 10.1002/mds.870070303. Mov Disord. 1992. PMID: 1620136
-
[Some problems on the clinical phenotype of Machado-Joseph disease in relation between their ages at onset].No To Shinkei. 1993 Mar;45(3):246-54. No To Shinkei. 1993. PMID: 8323819 Japanese.
-
[Autopsy cases of hereditary ataxia pathologically diagnosed as the Japanese type of Joseph disease--cliniconeuropathological findings].Seishin Shinkeigaku Zasshi. 1990;92(3):161-83. Seishin Shinkeigaku Zasshi. 1990. PMID: 2353076 Japanese.
-
[Linkage study of hereditary spinocerebellar ataxia, and probable correlation for the loci to the disease phenotypes].Rinsho Shinkeigaku. 1993 Dec;33(12):1285-7. Rinsho Shinkeigaku. 1993. PMID: 8174326 Review. Japanese.
-
Primary degeneration of the granular layer of the cerebellum. A study of 14 patients and review of the literature.Neuropediatrics. 1994 Aug;25(4):183-90. doi: 10.1055/s-2008-1073020. Neuropediatrics. 1994. PMID: 7824090 Review.
Cited by
-
Mouse models of human CAG repeat disorders.Brain Pathol. 1997 Jul;7(3):965-77. doi: 10.1111/j.1750-3639.1997.tb00896.x. Brain Pathol. 1997. PMID: 9217978 Free PMC article. Review.
-
Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3.Neurobiol Dis. 2021 Dec;160:105516. doi: 10.1016/j.nbd.2021.105516. Epub 2021 Sep 24. Neurobiol Dis. 2021. PMID: 34563642 Free PMC article.
-
Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.Mol Cell Biol. 2003 Sep;23(18):6469-83. doi: 10.1128/MCB.23.18.6469-6483.2003. Mol Cell Biol. 2003. PMID: 12944474 Free PMC article.
-
Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP3R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3.Int J Mol Sci. 2023 Jun 25;24(13):10606. doi: 10.3390/ijms241310606. Int J Mol Sci. 2023. PMID: 37445783 Free PMC article.
-
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.Ann Neurol. 2018 Jul;84(1):64-77. doi: 10.1002/ana.25264. Epub 2018 Aug 6. Ann Neurol. 2018. PMID: 29908063 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources